Elena Ridloff

Insider Reports History

Entity
Individual
Location
C/O Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego, CA
Signature
/s/ Jennifer Fitzpatrick, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elena Ridloff:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kronos Bio, Inc. Director Common Stock 25.3K $31.4K $1.24 Jun 25, 2024 Direct
Sionna Therapeutics, Inc. CFO & Head of Corp. Dev. Stock Option (Right to Buy) 158K Feb 6, 2025 Direct
Sionna Therapeutics, Inc. CFO & Head of Corp. Dev. Common Stock 124K Feb 6, 2025 Direct
Kronos Bio, Inc. Director Stock Option (Right to Buy) 17K Jun 25, 2024 Direct
Kymera Therapeutics, Inc. Director Stock Option (Right to Buy) 16K Jun 18, 2024 Direct

Insider Reports Filed by Elena Ridloff

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SION Sionna Therapeutics, Inc. Feb 6, 2025 1 $0 4 Feb 10, 2025 CFO & Head of Corp. Dev.
SION Sionna Therapeutics, Inc. Feb 6, 2025 0 $0 3 Feb 6, 2025 CFO & Head of Corp. Dev.
KRON Kronos Bio, Inc. Jun 25, 2024 2 $0 4 Jun 26, 2024 Director
KYMR Kymera Therapeutics, Inc. Jun 18, 2024 1 $0 4 Jun 20, 2024 Director
KRON Kronos Bio, Inc. Jun 22, 2023 2 $0 4 Jun 26, 2023 Director
KYMR Kymera Therapeutics, Inc. Jun 15, 2023 1 $0 4 Jun 20, 2023 Director
KYMR Kymera Therapeutics, Inc. Jun 29, 2022 1 $0 4 Jul 1, 2022 Director
KRON Kronos Bio, Inc. Jun 22, 2022 1 $0 4 Jun 29, 2022 Director
KYMR Kymera Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 16, 2022 Director
KRON Kronos Bio, Inc. Jun 22, 2021 1 $0 4 Jun 23, 2021 Director
KYMR Kymera Therapeutics, Inc. Jun 16, 2021 1 $0 4/A Apr 15, 2022 Director
KYMR Kymera Therapeutics, Inc. Mar 12, 2021 1 $0 4/A Apr 15, 2022 Director